Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

18 June 2002

Modulation of the susceptibility of intestinal bacteria to bacteriophages inresponse to Ag43 phase variation -- a hypothesis.

Grzegorz Wegrzyn, Mark S Thomas

Med Sci Monit 2002; 8(6): HY15-18 :: ID: 420804

Abstract

Escherichia coli is a Gram-negative bacterium which colonizes the intestinaltract of man and other animals. In addition to being a part of the normal bacterial flora of the humanintestine, there are a number of enteropathogenic strains of E. coli which cause infections ranging inconsequence from diarrhoea to colitis. Antigen 43 (Ag43) is the major phase-variable protein in the outermembrane of E. coli. One benefit for bacteria resulting from phase variation of surface antigens is usuallyascribed to evasion of host defences. However, results of recent studies indicate that infection of E.coli by different bacteriophages is inhibited in the presence of certain bile salts and carbohydrates(components present in the human intestine but absent in standard bacteriological media) when cells arein the 'OFF' state for production of Ag43. The inhibition of bacteriophage development was found to bedue to a significant impairment in the process of phage adsorption and evidence was presented for thebinding of phage to Ag43. Here we present a hypothesis that in the case of Ag43, phase-variation mightbenefit the host bacterium by modulating the susceptibility to phage infection in the gut. If this hypothesisis true, it may have important implications not only for basic research but also for development of bacteriophagetherapy, a re-discovered method of treatment of patients with infectious diseases.

Keywords: Antigens, Bacterial, Bacterial Outer Membrane Proteins, Coliphages, Escherichia coli, Escherichia coli Proteins, Research Support, Non-U.S. Gov

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750